Gangrenous cholecystitis is the most common complication of acute cholecystitis. There is no research using machine learning models to construct predictive diagnostic models for gangrenous cholecystitis.
This study reviewed the clinical data of 2023 cholecystectomy patients admitted to our center between January 1, 2015, and May 31, 2015, it includes demographic, clinical features, laboratory and imaging indexes, and constructs five commonly used Decision Tree, SVM, Random Forest, XGBoost, AdaBoost models, feature subsets are selected by Recursive Feature Elimination with Cross-Validation and the importance of variables in each model, model performance is evaluated by Balanced accuracy, Recall, Precision, F1score, and the Precision-Recall(PR) curve, and the final results are verified by independent external validation sets.
Study Type
OBSERVATIONAL
Enrollment
1,006
Observational
The Second Hospital of Dalian Medical University
Dalian, Liaoning, China
pathological diagnosis of patients with cholecystectomy
Check the patient's pathological report and whether the pathological description contains phenomena such as full layer ischemic necrosis and ulceration of the gallbladder wall. Diagnose as gangrenous cholecystitis or non-gangrenous cholecystitis.
Time frame: 30 days
The predictive performance of diagnostic prediction models
The predictive diagnosis was obtained by the model and each predictive variable, and the metric (Accuracy, Recall, Precision, F1score) of the model was obtained by comparing with the actual pathological diagnosis.
Time frame: through study completion, an average of 4 months
WBC value (10*9/L)
Correlation between WBC and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months
Alanine transaminase value (ALT, U/L)
Correlation between liver function and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months
D-dimer value
Correlation between coagulopathy and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months
Fibrinogen value (g/L)
Correlation between coagulopathy and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
BMI (Kg/m2)
Correlation between obesity level and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months
Gallbladder wallness (cm)
Correlation between Gallbladder wallness and patients with gangrenous cholecystitis and non-gangrenous cholecystitis
Time frame: through study completion, an average of 4 months